Learn how aggressive neuroendocrine carcinoma disrupts daily life—and why rapid treatment, strong caregiver support, and navigation resources matter. In this episode, ‘Current Treatments and Biomarker ...
Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
Wastewater signals suggest increasing SARS-CoV-2 circulation despite low national baselines, reinforcing surveillance as an early indicator rather than a definitive predictor of near-term clinical ...
Senate Democrats introduced a bill to cap out-of-pocket costs at $5000 for traditional Medicare beneficiaries and expand low-income assistance. Traditional Medicare does not currently have a limit on ...
COA’s AI Playbook provides a structured, practice-oriented framework to prioritize AI use cases, align stakeholders, and ...
On National HIV Testing Day, getting tested remains a gateway to prevention and treatment, but improving access alone is not enough. Expanding access to PrEP, PEP, pharmacists, long-acting therapies, ...
As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...
Deloitte's Pete Lyons explains the confidence gap, diverging biopharmaceutical and medical technology risks, and what separates real AI value from activity. 259 Prospect Plains Rd, Bldg H Cranbury, NJ ...
A nested case-control linkage of California births to cancer registry data captured 1,221 EOCRC cases (diagnosed ages 0–39) and 61,050 frequency-matched controls for multivariable modeling. Male sex ...
This segment introduces the evolving treatment landscape in hormone receptor–positive, HER2-negative metastatic breast cancer, with a focus on the growing clinical relevance of ESR1 mutations. Dr.
AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...
Earlier, systematic supportive and palliative integration, plus streamlined logistics and clearer counseling on novel-therapy AE profiles, could reduce household disruption during treatment and ...